Skip to main content

Quick Connect

CPHI Japan, 2023

Join us to expand your horizons
in the Japanese pharma market
Meet Dr.Reddy’s API team at

CPHI Japan, 2023

Booth 5J-20
19-21 April 2023
Tokyo Big Sight, Tokyo,Japan
Contact Us

Our Team at
CPHI Japan

About CPHI Japan

CPHI Japan is the premier event for the pharmaceutical industry in Japan, providing a platform for international companies to connect and do business with key players in the Japanese market. In its 20th anniversary, the event is expected to attract over 200 exhibitors from across the entire pharmaceutical supply chain, showcasing the latest products, solutions, and innovations in the industry.

Attendees can expect to discover the latest products and services from ingredients, contract services, and biopharma to technology, packaging, and machinery. They will also have the opportunity to meet and network with industry leaders, search for potential partners, and arrange meetings with potential partners online through the event's chat service.

Whether you are a large multinational corporation or a small start-up, CPHI Japan provides the perfect platform to expand your horizons in the Japanese pharmaceutical market. Join us at the event and take advantage of the unique opportunities to connect and grow your business.

About Dr.Reddy’s API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.


Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.


Our Achievement

Manufacturing Location

Dr. Reddy’s API  Manufacturing Locations


© 2023 Dr. Reddy’s Laboratories Ltd. All rights reserved.


No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.